In 2024, Medicaid providers in Ogdensburg submitted $11,133 in claims for services under the Coronavirus Diagnostic Panel category, U.S. Department of Health and Human Services Medicaid Provider Spending data shows. This amount marks a 56.5% rise from the $7,112 billed for the same services in 2023.
Medicaid, a state-administered public health insurance initiative jointly funded by federal and state governments, covers low-income families and individuals, seniors, children, and those with disabilities, positioning it among the largest U.S. health care programs.
Since Medicaid payments rely on public funds, shifts in local claim totals offer insight into how a community allocates its health care resources.
The “Coronavirus Diagnostic Panel” category represents Medicaid-billed services grouped by care type, based on standardized HCPCS and CPT code sets. In this analysis, each code was classified into a single service group using set prefixes and numeric intervals, which allows related services to be tracked together while maintaining consistent rankings and preventing duplicate counts.
Despite increases across multiple categories, Coronavirus Diagnostic Panel ranked 11th among Medicaid payment categories in Ogdensburg for 2024.
Statewide in New York, this category was ranked 27th for total Medicaid reimbursements in 2024.
From 2019 to 2024, Ogdensburg saw Medicaid payments for the Coronavirus Diagnostic Panel category increase by $52,924, or 82.6%. Certain periods, including 2023 and 2022, saw particularly strong year-over-year gains.
Although payments for the Coronavirus Diagnostic Panel were dispersed throughout Ogdensburg, spending was primarily concentrated in a small number of ZIP codes. In 2024, ZIP code 13669 recorded the highest amount, with $11,133, accounting for 100% of all category payments in the city for the year.
Payments within the Coronavirus Diagnostic Panel category were also focused among a limited set of billing codes.
For reference, while Ogdensburg’s Medicaid payments for this category grew 56.5% from 2023 to 2024, the increase across all Medicaid claim categories in the city during that period was 44.3%.
The Centers for Medicare & Medicaid Services reports that combined federal and state spending on Medicaid reached roughly $871.7 billion in fiscal 2023, equating to about 18% of overall U.S. health expenditures—up significantly from nearly $613.5 billion in 2019, ahead of the COVID-19 pandemic.
This overall increase amounts to about 40% growth in several years, largely due to higher enrollment and increased utilization during and after the pandemic.
Recent federal budget measures under the Trump administration included proposals to substantially cut federal Medicaid funding and restructure the program. For example, the “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid spending by more than $1 trillion over the next 10 years, while introducing work requirements and increased cost sharing that may curtail coverage and funding for some program participants. These policy changes are projected to shift additional costs to states and may limit federal Medicaid support growth, as the program continues to provide health care to tens of millions of Americans.
| Year | Total Medicaid Payments | % Change From Previous Year |
|---|---|---|
| 2020 | $64,057 | – |
| 2023 | $7,111 | -88.9% |
| 2024 | $11,133 | 56.5% |
| Rank | Category | Medicaid Payments | Share of City Total |
|---|---|---|---|
| 1 | Medicine Services and Procedures | $1,215,990 | 30.8% |
| 2 | Evaluation and Management | $985,106 | 25% |
| 3 | Alcohol and Drug Abuse Treatment | $717,273 | 18.2% |
| 4 | Surgery | $300,947 | 7.6% |
| 5 | Pathology and Laboratory Procedures | $233,240 | 5.9% |
| 6 | Ambulance and Other Transport Services and Supplies | $196,312 | 5% |
| 7 | Radiology Procedures | $158,104 | 4% |
| 8 | Durable Medical Equipment | $73,777 | 1.9% |
| 9 | Procedures / Professional Services | $35,355 | 0.9% |
| 10 | Medical And Surgical Supplies | $12,878 | 0.3% |
| 11 | Coronavirus Diagnostic Panel | $11,133 | 0.3% |
| 12 | Temporary National Codes (Non-Medicare) | $2,044 | 0.1% |
| 13 | Drugs Administered Other than Oral Method | $1,814 | <0.1% |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| U0002 | Covid-19 lab test non-cdc | $11,133 | 9 |
Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.
Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.
